April 06, 2019
2 min read

Top recent testosterone therapy news stories

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Endocrine Today has compiled a list of the top recent news reports related to testosterone therapy. In March, Healio.com/Endocrinology readers were interested in essential oils disrupting endocrine function, semaglutide producing weight loss and the safety of an artificial pancreas.

New testosterone therapies offer options for men with hypogonadism

Three new testosterone therapies offer innovative drug delivery options for men with hypogonadism that improve patient satisfaction while avoiding risks related to secondary exposure.


Testosterone therapy provides multiple benefits in obesity treatment

Long-term testosterone therapy may not only help men with obesity and hypogonadism to lose weight, but it may have other useful effects on metabolic function and protect against obesity comorbidities.


Testosterone improves libido, quality of life in women with low sexual desire

Premenopausal and postmenopausal women reporting a persistent, low libido that profoundly impairs quality of life can experience an improvement in symptoms with transdermal testosterone, but clinicians must consider several important points before prescribing the therapy.


FDA approves oral testosterone capsule for men with hypogonadism

The FDA approved testosterone undecanoate in an oral capsule to treat men with certain forms of hypogonadism, the agency announced in a press release. The approval of Jatenzo (Clarus Therapeutics) marks the first new oral testosterone replacement product in more than 60 years.


Testosterone therapy shows promise as potential weight-loss tool

Men with obesity and hypogonadism who underwent testosterone therapy achieved greater 10-year weight loss and experienced protective effects against cardiovascular and mortality risks compared with similar men who did not receive testosterone.


Low-dose hCG can prevent sterility in men prescribed testosterone

Low-dose human chorionic gonadotropin, or hCG, may preserve spermatogenesis in men with hypogonadism treated with intramuscular or transdermal testosterone replacement therapy.


Men's birth control pill shows promise in monthlong study

Healthy men assigned to a daily oral modified testosterone pill for 1 month experienced a decrease in serum testosterone consistent with effective contraception while maintaining androgenic traits such as sexual function.


Transgender men prescribed testosterone therapy may have preserved ovarian function

At least 1 year of testosterone therapy did not reduce anti-Müllerian hormone levels or antral follicular count in a cohort of transgender men in Israel, providing evidence for preserved ovarian reserve.


Testosterone therapy reduces CV events, death in men with hypogonadism

Low testosterone is associated with increased all-cause and cardiovascular mortality, and testosterone replacement therapy in men with a confirmed diagnosis of hypogonadism is associated with reduced CV events and CV death.


Endogenous testosterone may influence cardiovascular health in men

Thromboembolism, heart failure and myocardial infarction may be linked to high levels of endogenous testosterone in men, according to findings from a genome-wide association study published in BMJ.